{"entity":{"type":"insider","cik":"0001821936","url":"/insider/0001821936","json_url":"/insider/0001821936.json","name":"Valor Equity Capital IV LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":1,"first":"2024-11-05","last":"2024-11-05","span_basis":"filed_date"},"name_variants":[{"name":"Valor Equity Capital IV LLC","source":"filing","n_filings":1,"first_seen":"2024-11-05","last_seen":"2024-11-05"}],"transactions":[{"id":2698977,"accession":"0001213900-24-094654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-094654","line_url":"/filing/0001213900-24-094654#line-2","is_derivative":false,"issuer_cik":"0001495158","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001495158","owner_cik":null,"owner_name":"VALOR EQUITY PARTNERS IV-A L.P.; Valor IV Pharma Holdings, LLC; Valor Equity Associates IV L.P.; Sabater Juan A.; Valor Equity Capital IV LLC; VALOR EQUITY PARTNERS IV-B L.P.; Valor Management L.P.; VALOR EQUITY PARTNERS IV L.P.; Gracias Antonio J.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":30.3025,"price_display":"30.30","price_state":"stated","total_value":18181500.0,"total_display":"18,181,500.00","shares_owned_after":6618033.0,"shares_owned_after_display":"6,618,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-05","filed_date":"2024-11-05","scope":"insider"},{"id":2698972,"accession":"0001213900-24-094654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-094654","line_url":"/filing/0001213900-24-094654#line-1","is_derivative":false,"issuer_cik":"0001495158","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001495158","owner_cik":null,"owner_name":"VALOR EQUITY PARTNERS IV-A L.P.; Valor IV Pharma Holdings, LLC; Valor Equity Associates IV L.P.; Sabater Juan A.; Valor Equity Capital IV LLC; VALOR EQUITY PARTNERS IV-B L.P.; Valor Management L.P.; VALOR EQUITY PARTNERS IV L.P.; Gracias Antonio J.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000000.0,"shares_display":"4,000,000","price_per_share":30.3025,"price_display":"30.30","price_state":"stated","total_value":121210000.0,"total_display":"121,210,000.00","shares_owned_after":7218033.0,"shares_owned_after_display":"7,218,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802665","name":"Harmony Biosciences Holdings, Inc.","url":"/issuer/0001802665","role":"Ten percent owner","n_filings":1,"first_seen":"2024-11-05","last_seen":"2024-11-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001821936","retrieved_at":"2026-08-21T12:19:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}